ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 578,25
-0,71%
Dow Jones
40 211,72
0,53%
DAX
18 498,21
-0,55%
Brent Oil
83,755
-0,69%
Bitcoin
63 189,40
-2,56%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
11/09/201714h42Dow Jones NewsTeva Finally Appoints New Chief Executive After Months of Speculation -- 3rd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
11/09/201712h46Dow Jones NewsTeva Names Kare Schultz as New Chief Executive -- 2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
11/09/201712h05Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
11/09/201710h03Dow Jones NewsTeva Names Kare Schultz as New Chief Executive -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
11/09/201708h04Business WireTeva Names Kåre Schultz as President and Chief Executive OfficerNYSE:TEVATeva Pharmaceutical Industries Ltd
09/09/201714h00Business WireTeva Showcases Data Demonstrating Potential of Fremanezumab to Address Significant Unmet Need in Patients with Chronic & Epis...NYSE:TEVATeva Pharmaceutical Industries Ltd
09/09/201709h02Dow Jones NewsPatents Take Refuge With Indian Tribe -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
08/09/201722h59Dow Jones NewsAllergan Partners With Indian Tribe to Protect Drug Patents -- 3rd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
08/09/201721h49Dow Jones NewsAllergan Partners With Indian Tribe to Protect Drug Patents -- 2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
08/09/201721h31Dow Jones NewsAllergan Partners With Indian Tribe to Protect Drug Patents -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
08/09/201720h07Dow Jones NewsAllergan Partners With Indian Tribe to Protect Drug PatentsNYSE:TEVATeva Pharmaceutical Industries Ltd
08/09/201701h10Dow Jones NewsNew Mexico Sues Drugmakers, Distributors Over Opioid CrisisNYSE:TEVATeva Pharmaceutical Industries Ltd
07/09/201723h13Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NYSE:TEVATeva Pharmaceutical Industries Ltd
06/09/201714h00Business WireTeva To Present New Asthma and COPD Data at the 2017 European Respiratory Society (ERS) International CongressNYSE:TEVATeva Pharmaceutical Industries Ltd
05/09/201714h00Business WireTeva to Present Fremanezumab Data on Migraine Prevention at the 18th Congress of the International Headache SocietyNYSE:TEVATeva Pharmaceutical Industries Ltd
30/08/201721h53Business WireTeva Announces FDA Approval of AUSTEDO® (deutetrabenazine) Tablets for the Treatment of Tardive Dyskinesia in AdultsNYSE:TEVATeva Pharmaceutical Industries Ltd
24/08/201701h30Dow Jones NewsADRs End Mostly HigherNYSE:TEVATeva Pharmaceutical Industries Ltd
23/08/201716h45PR Newswire (US)Kaufman, Coren & Ress, P.C. Files Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. (TEVA)NYSE:TEVATeva Pharmaceutical Industries Ltd
19/08/201701h19Dow Jones NewsCorrection to Biogen Treads Tricky Path Between Politicians, Investors ArticleNYSE:TEVATeva Pharmaceutical Industries Ltd
18/08/201719h37Business WireTeva Announces Exclusive Launch of Generic Axiron® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
10/08/201709h02Dow Jones NewsMylan Cuts View On Drug Delays -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
10/08/201700h17Dow Jones NewsMylan Defers Product Launches -- 3rd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
09/08/201720h00Dow Jones NewsMylan Defers Product Launches -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
09/08/201719h33Dow Jones NewsCorrection to article on Mylan earningsNYSE:TEVATeva Pharmaceutical Industries Ltd
08/08/201700h17Dow Jones NewsADRs End Mostly Higher; Alibaba, Teva Trade ActivelyNYSE:TEVATeva Pharmaceutical Industries Ltd
07/08/201714h00Business WireTeva Announces FDA Approval of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation AerosolNYSE:TEVATeva Pharmaceutical Industries Ltd
05/08/201709h02Dow Jones NewsPrice War Squeezes Generic-Drug Firms -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
05/08/201700h44Dow Jones NewsFalling U.S. Generic Drug Prices Hurt Manufacturers, Wholesalers -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
04/08/201722h34Dow Jones NewsFalling U.S. Generic Drug Prices Hurt Manufacturers, WholesalersNYSE:TEVATeva Pharmaceutical Industries Ltd
04/08/201709h02Dow Jones NewsDrug Giant's Stock Tumbles on Outlook -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
VIV
Vivendi
NYSE
NKE
Nike
SPI
SP500
S&P 500
NYSE
DIS
Walt Disney
EU
AI
Air Liquide
EU
ORA
Orange
NYSE
JPM
JP Morgan Chase
NYSE
MRK
Merck
NASDAQ
NVDA
NVIDIA
EU
RNO
Renault
EU
CAP
Capgemini
NYSE
MCD
McDonalds
EU
EN
Bouygues
EU
LR
Legrand
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés